{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:57:50Z","timestamp":1790780270754,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Bijzonder Onderzoeksfonds UHasselt","award":["BOF22OWB03"],"award-info":[{"award-number":["BOF22OWB03"]}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["T004018N"],"award-info":[{"award-number":["T004018N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"DOI":"10.1007\/s10198-026-01995-4","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:18:42Z","timestamp":1790777922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Remote and self-monitoring for pregnant women at risk of gestational hypertensive disorders: a cost-effectiveness analysis"],"prefix":"10.1007","author":[{"given":"Marie-Lien","family":"Gerits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Bielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien","family":"Lanssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Marneffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PREMOM II-consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"1995_CR1","volume-title":"Williams Obstetrics","author":"FG Cunningham","year":"2019","unstructured":"Cunningham, F. G., K. J. Lenovo, S. L. Bloom, J. S. Dashe, B. L. Hoffman, and B. M. Casey et al. 2019. Williams Obstetrics. New York: McGraw-Hill Education."},{"key":"1995_CR2","unstructured":"Queensland Government. 2021. Clinical Guideline: Hypertension and pregnancy. https:\/\/www.health.qld.gov.au\/qcg\/publications#maternity Accessed 11 April 2025."},{"key":"1995_CR3","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.107928","author":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy","year":"2000","unstructured":"National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. 2000. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. American journal of obstetrics and gynecology. https:\/\/doi.org\/10.1067\/mob.2000.107928","journal-title":"American journal of obstetrics and gynecology"},{"key":"1995_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2014.02.001","author":"A Tranquilli","year":"2014","unstructured":"Tranquilli, A., G. Dekker, L. Magee, J. Roberts, B. Sibai, and W. Steyn et al. 2014. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertension: An International Journal of Women\u2019s Cardiovascular Health. https:\/\/doi.org\/10.1016\/j.preghy.2014.02.001","journal-title":"Pregnancy Hypertension: An International Journal of Women\u2019s Cardiovascular Health"},{"key":"1995_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2012.02.001","author":"S Petrou","year":"2012","unstructured":"Petrou, S., and K. Khan. 2012. Economic costs associated with moderate and late preterm birth: primary and secondary evidence. Seminars in Fetal and Neonatal Medicine. https:\/\/doi.org\/10.1016\/j.siny.2012.02.001","journal-title":"Seminars in Fetal and Neonatal Medicine"},{"key":"1995_CR6","doi-asserted-by":"publisher","DOI":"10.3238\/artebl.2009.0733","author":"W Rath","year":"2009","unstructured":"Rath, W., and T. Fischer. 2009. The diagnosis and treatment of hypertensive disorders of pregnancy: new findings for antenatal and inpatient care. Deutsches \u00c4rzteblatt International. https:\/\/doi.org\/10.3238\/artebl.2009.0733","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"1995_CR7","unstructured":"Nadereh, P., A. E. Martinez, J. M. Jones, K. D. Gregory, L. Korst, and G. F. Kominski. 2013. Costs of Gestational Hypertensive Disorders in California: Hypertension, Preeclampsia, and Eclampsia. https:\/\/healthpolicy.ucla.edu\/our-work\/publications\/costs-gestational-hypertensive-disorders-california-hypertension-preeclampsia-and-eclampsia"},{"key":"1995_CR8","doi-asserted-by":"publisher","DOI":"10.3109\/08037051.2015.1070599","author":"S Bonafini","year":"2015","unstructured":"Bonafini, S., and C. Fava. 2015. Home blood pressure measurements: advantages and disadvantages compared to office and ambulatory monitoring. Blood pressure. https:\/\/doi.org\/10.3109\/08037051.2015.1070599","journal-title":"Blood pressure"},{"key":"1995_CR9","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2015.10.2.95","author":"J George","year":"2015","unstructured":"George, J., and T. MacDonald. 2015. Home blood pressure monitoring. European Cardiology Review. https:\/\/doi.org\/10.15420\/ecr.2015.10.2.95","journal-title":"European Cardiology Review"},{"key":"1995_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.16059","author":"T Rajkumar","year":"2025","unstructured":"Rajkumar, T., A. Hennessy, and A. Makris. 2025. Remote blood pressure monitoring in women at risk of or with hypertensive disorders of pregnancy: A systematic review and meta-analysis. International Journal of Gynecology & Obstetrics. https:\/\/doi.org\/10.1002\/ijgo.16059","journal-title":"International Journal of Gynecology & Obstetrics"},{"key":"1995_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2023.12.007","author":"F Forna","year":"2024","unstructured":"Forna, F., E. Gibson, A. Miles, P. Seda, F. Lobelo, and A. Mbanya et al. 2024. Improving obstetric and perinatal outcomes with a remote patient monitoring program for hypertension in a large integrated care system. Pregnancy Hypertension. https:\/\/doi.org\/10.1016\/j.preghy.2023.12.007","journal-title":"Pregnancy Hypertension"},{"key":"1995_CR12","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.6552","author":"D Lanssens","year":"2017","unstructured":"Lanssens, D., T. Vandenberk, C. J. Smeets, H. De Canni\u00e8re, G. Molenberghs, and A. Van Moerbeke et al. 2017. Remote monitoring of hypertension diseases in pregnancy: a pilot study. JMIR mHealth and uHealth. https:\/\/doi.org\/10.2196\/mhealth.6552","journal-title":"JMIR mHealth and uHealth"},{"key":"1995_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2018.02.015","author":"D Lanssens","year":"2018","unstructured":"Lanssens, D., S. Vonck, V. Storms, I. M. Thijs, L. Grieten, and W. Gyselaers. 2018. The impact of a remote monitoring program on the prenatal follow-up of women with gestational hypertensive disorders. European Journal of Obstetrics & Gynecology and Reproductive Biology. https:\/\/doi.org\/10.1016\/j.ejogrb.2018.02.015","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"1995_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.4726","author":"LC Chappell","year":"2022","unstructured":"Chappell, L. C., K. L. Tucker, U. Galal, L.-M. Yu, H. Campbell, and O. Rivero-Arias et al. 2022. Effect of self-monitoring of blood pressure on blood pressure control in pregnant individuals with chronic or gestational hypertension: the BUMP 2 randomized clinical trial. Journal Of The American Medical Association. https:\/\/doi.org\/10.1001\/jama.2022.4726","journal-title":"Journal Of The American Medical Association"},{"key":"1995_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2019.07.006","author":"E Kalafat","year":"2019","unstructured":"Kalafat, E., K. Leslie, A. Bhide, B. Thilaganathan, and A. Khalil. 2019. Pregnancy outcomes following home blood pressure monitoring in gestational hypertension. Pregnancy Hypertension. https:\/\/doi.org\/10.1016\/j.preghy.2019.07.006","journal-title":"Pregnancy Hypertension"},{"key":"1995_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2020.07.006","author":"JF van den Heuvel","year":"2020","unstructured":"van den Heuvel, J. F., A. T. Lely, J. J. Huisman, J. C. Trappenburg, A. Franx, and M. N. Bekker. 2020. SAFE@ HOME: Digital health platform facilitating a new care path for women at increased risk of preeclampsia\u2013A case-control study. Pregnancy Hypertension. https:\/\/doi.org\/10.1016\/j.preghy.2020.07.006","journal-title":"Pregnancy Hypertension"},{"key":"1995_CR17","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.9552","author":"D Lanssens","year":"2018","unstructured":"Lanssens, D., T. Vandenberk, C. J. Smeets, H. De Canni\u00e8re, S. Vonck, and J. Claessens et al. 2018. Prenatal remote monitoring of women with gestational hypertensive diseases: cost analysis. Journal of medical Internet research. https:\/\/doi.org\/10.2196\/jmir.9552","journal-title":"Journal of medical Internet research"},{"key":"1995_CR18","doi-asserted-by":"publisher","unstructured":"Lanssens, D., S. Vonck, T. Vandenberk, C. Schraepen, V. Storms, and I. M. Thijs et al. 2019. A prenatal remote monitoring program in pregnancies complicated with gestational hypertensive disorders: what are the contributors to the cost savings? Telemed and e-Health https:\/\/doi.org\/10.1089\/tmj.2018.0147","DOI":"10.1089\/tmj.2018.0147"},{"key":"1995_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2021.03.004","author":"JF van den Heuvel","year":"2021","unstructured":"van den Heuvel, J. F., C. van Lieshout, A. Franx, G. Frederix, and M. N. Bekker. 2021. SAFE@ HOME: Cost analysis of a new care pathway including a digital health platform for women at increased risk of preeclampsia. Pregnancy Hypertension. https:\/\/doi.org\/10.1016\/j.preghy.2021.03.004","journal-title":"Pregnancy Hypertension"},{"key":"1995_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/uog.19041","author":"G Xydopoulos","year":"2019","unstructured":"Xydopoulos, G., H. Perry, E. Sheehan, B. Thilaganathan, R. Fordham, and A. Khalil. 2019. Home blood-pressure monitoring in a hypertensive pregnant population: cost\u2010minimization study. Ultrasound in Obstetrics & Gynecology. https:\/\/doi.org\/10.1002\/uog.19041","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"key":"1995_CR21","doi-asserted-by":"publisher","unstructured":"Campbell, H. E., L. C. Chappell, R. J. McManus, K. L. Tucker, C. Crawford, and M. Green et al. 2024. Detection and control of pregnancy hypertension using Self-Monitoring of blood pressure with automated telemonitoring: cost analyses of the BUMP randomized trials. Hypertension https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.22059","DOI":"10.1161\/HYPERTENSIONAHA.123.22059"},{"key":"1995_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2024.101442","author":"JY Mei","year":"2024","unstructured":"Mei, J. Y., A. Hauspurg, K. Corry-Saavedra, T. A. Nguyen, A. Murphy, and E. S. Miller. 2024. Remote blood pressure management for postpartum hypertension: a cost-effectiveness analysis. American Journal of Obstetrics & Gynecology MFM. https:\/\/doi.org\/10.1016\/j.ajogmf.2024.101442","journal-title":"American Journal of Obstetrics & Gynecology MFM"},{"key":"1995_CR23","unstructured":"Lanssens, D. 2026. The PREMOM II study: What is the added value of remote monitoring in prenatal follow-up for women at risk of hypertensive disorders of pregnancy? European Journal of Midwifery 10."},{"key":"1995_CR24","doi-asserted-by":"publisher","DOI":"10.47671\/TVG.80.24.079","author":"M-L Gerits","year":"2025","unstructured":"Gerits, M.-L., S. Bielen, D. Lanssens, and J. Luyten. 2025. Door de ogen van de pati\u00ebnt: Telemonitoring en zelfmonitoring voor zwangeren met een verhoogd risico op hypertensie. Tijdschrift Voor Geneeskunde En Gezondheidszorg. https:\/\/doi.org\/10.47671\/TVG.80.24.079","journal-title":"Tijdschrift Voor Geneeskunde En Gezondheidszorg"},{"key":"1995_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-020-03291-2","author":"D Lanssens","year":"2020","unstructured":"Lanssens, D., I. M. Thijs, and W. Gyselaers. 2020. Design of the P regnancy RE mote MO nitoring II study (PREMOM II): a multicenter, randomized controlled trial of remote monitoring for gestational hypertensive disorders. BMC Pregnancy and Childbirth. https:\/\/doi.org\/10.1186\/s12884-020-03291-2","journal-title":"BMC Pregnancy and Childbirth"},{"key":"1995_CR26","unstructured":"The Fetal Medicine Foundation. 2025. Risk assessment - Risk for preeclampsia. https:\/\/fetalmedicine.org\/research\/assess\/preeclampsia\/first-trimester Accessed 11 April 2025."},{"key":"1995_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.07.020","author":"P Chaemsaithong","year":"2022","unstructured":"Chaemsaithong, P., D. S. Sahota, and L. C. Poon. 2022. First trimester preeclampsia screening and prediction. American journal of obstetrics and gynecology. https:\/\/doi.org\/10.1016\/j.ajog.2020.07.020","journal-title":"American journal of obstetrics and gynecology"},{"key":"1995_CR28","unstructured":"National Institute for Health and Care Excellence. 2025. Hypertension in pregnancy: diagnosis and management. https:\/\/www.nice.org.uk\/guidance\/ng133\/chapter\/Recommendations#management-of-gestational-hypertension Accessed 11 April 2025."},{"key":"1995_CR29","unstructured":"Domus Medica. 2023. Zwangerschapsbegeleiding. https:\/\/www.domusmedica.be\/richtlijnen\/zwangerschapsbegeleiding Accessed 9 November 2023."},{"key":"1995_CR30","unstructured":"Goemaes, R., E. Fomenko, M. Laubach, K. D. Coen, K. Roelens, and A. Bogaerts. 2021. Perinatale gezondheid in Vlaanderen - Jaar 2021."},{"key":"1995_CR31","unstructured":"Goemaes, R., E. Fomenko, M. Laubach, K. D. Coen, A. Bogaerts, and K. Roelens. 2022. Perinatale gezondheid in Vlaanderen - Jaar 2022."},{"key":"1995_CR32","unstructured":"Goemaes, R., E. Fomenko, M. Laubach, K. D. Coen, K. Roelens, and A. Bogaerts. 2023. Perinatale gezondheid in Vlaanderen - Jaar 2023."},{"key":"1995_CR33","unstructured":"Goemaes, R., E. Fomenko, M. Laubach, K. D. Coen, K. Roelens, and A. Bogaerts. 2024. Perinatale gezondheid in Vlaanderen \u2013 Jaar 2023."},{"key":"1995_CR34","doi-asserted-by":"crossref","unstructured":"Neyt, M., N. Thiry, and I. Cleemput. 2025. Belgian guidelines for economic evaluations and budget impact analysis: Third edition. https:\/\/kce.fgov.be\/en\/belgian-guidelines-for-economic-evaluations-and-budget-impact-analyses-third-edition","DOI":"10.57598\/R400C"},{"key":"1995_CR35","unstructured":"NICE. 2025. Changes to NICE\u2019s cost-effectiveness thresholds confirmed. https:\/\/www.nice.org.uk\/news\/articles\/changes-to-nice-s-cost-effectiveness-thresholds-confirmed? Accessed."},{"key":"1995_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-022-00353-3","author":"N Bouckaert","year":"2022","unstructured":"Bouckaert, N., I. Cleemput, S. Devriese, and S. Gerkens. 2022. An EQ-5D-5L value set for Belgium. PharmacoEconomics-Open. https:\/\/doi.org\/10.1007\/s41669-022-00353-3","journal-title":"PharmacoEconomics-Open"},{"key":"1995_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0623-8","author":"MF Janssen","year":"2018","unstructured":"Janssen, M. F., G. J. Bonsel, and N. Luo. 2018. Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries. Pharmacoeconomics. https:\/\/doi.org\/10.1007\/s40273-018-0623-8","journal-title":"Pharmacoeconomics"},{"key":"1995_CR38","doi-asserted-by":"publisher","unstructured":"Bekker, M. N., M. P. Koster, W. R. Keusters, W. Ganzevoort, J. M. de Haan-Jebbink, and K. L. Deurloo et al. 2023. Home telemonitoring versus hospital care in complicated pregnancies in the Netherlands: a randomised, controlled non-inferiority trial (HoTeL). The Lancet Digital Health https:\/\/doi.org\/10.1016\/S2589-7500(22)00231-X","DOI":"10.1016\/S2589-7500(22)00231-X"},{"key":"1995_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2019.09.018","author":"LM Pealing","year":"2019","unstructured":"Pealing, L. M., K. L. Tucker, L. H. Mackillop, C. Crawford, H. Wilson, and A. Nickless et al. 2019. A randomised controlled trial of blood pressure self-monitoring in the management of hypertensive pregnancy. OPTIMUM-BP: A feasibility trial. Pregnancy hypertension. https:\/\/doi.org\/10.1016\/j.preghy.2019.09.018","journal-title":"Pregnancy hypertension"},{"key":"1995_CR40","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.4712","author":"KL Tucker","year":"2022","unstructured":"Tucker, K. L., S. Mort, L.-M. Yu, H. Campbell, O. Rivero-Arias, and H. M. Wilson et al. 2022. Effect of self-monitoring of blood pressure on diagnosis of hypertension during higher-risk pregnancy: the BUMP 1 randomized clinical trial. Journal Of The American Medical Association. https:\/\/doi.org\/10.1001\/jama.2022.4712","journal-title":"Journal Of The American Medical Association"},{"key":"1995_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-9-26","author":"AS Pickard","year":"2011","unstructured":"Pickard, A. S., Y. Yang, and T. A. Lee. 2011. Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health and Quality of Life Outcomes. https:\/\/doi.org\/10.1186\/1477-7525-9-26","journal-title":"Health and Quality of Life Outcomes"},{"key":"1995_CR42","unstructured":"Euroqol. 2025. EQ-5D-Y-5L. https:\/\/euroqol.org\/information-and-support\/euroqol-instruments\/eq-5d-y-5l\/ Accessed 2 October 2025."},{"key":"1995_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.02.003","author":"LJ Cheng","year":"2021","unstructured":"Cheng, L. J., R.L.-Y. Tan, and N. Luo. 2021. Measurement properties of the EQ VAS around the globe: a systematic review and meta-regression analysis. Value in Health. https:\/\/doi.org\/10.1016\/j.jval.2021.02.003","journal-title":"Value in Health"},{"key":"1995_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.12.009","author":"R Jabrayilov","year":"2019","unstructured":"Jabrayilov, R., K. M. Vermeulen, P. Detzel, L. Dainelli, A. D. van Asselt, and P. F. Krabbe. 2019. Valuing health status in the first year of life: the infant health-related quality of life instrument. Value in Health. https:\/\/doi.org\/10.1016\/j.jval.2018.12.009","journal-title":"Value in Health"},{"key":"1995_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1673003","author":"S Ray","year":"2025","unstructured":"Ray, S., S. Suri, and G. Verlato. 2025. The first 1000 days: window of opportunity for child health and development. Frontiers in Nutrition. https:\/\/doi.org\/10.3389\/fnut.2025.1673003","journal-title":"Frontiers in Nutrition"}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-026-01995-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-026-01995-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-026-01995-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:18:46Z","timestamp":1790777926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10198-026-01995-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":45,"alternative-id":["1995"],"URL":"https:\/\/doi.org\/10.1007\/s10198-026-01995-4","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethics committee at Universitair Ziekenhuis Antwerpen (UZA; Wilrijk) approved the PREMOM II study in July 2019 (Belgium Registration Number: BE300201938651). The local ethics committees at Ziekenhuis Oost-Limburg (ZOL), Universiteit Ziekenhuis Leuven (Leuven), AZ Sint Jan (Bruges), and AZ Sint Lucas (Bruges) provided advice to the ethics committee at UZA before the study was approved.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants provided consent to participate.","order":2,"name":"Ethics","label":"Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}